Siemens Healthcare

/Siemens Healthcare
6 11, 2017

Siemens Healthineers Completes Epocal Acquisition from Alere

By |November 6th, 2017|Siemens Healthcare|Comments Off on Siemens Healthineers Completes Epocal Acquisition from Alere

This is an update on the August 14, 2017 blog "Siemens Healthineers to Acquire Epocal from Alere" Siemens Healthineers, the separately managed healthcare business of Siemens AG has completed its Epocal acquisition that was announced earlier. By incorporating Epocal's products to its POC Ecosystem™ solution, Siemens now enables customized testing offerings based on individual facility [...]

20 10, 2017

Hematek® 3000 – Semi-automated Slide Staining System for Labs of all Sizes

By |October 20th, 2017|Siemens Healthcare|Comments Off on Hematek® 3000 – Semi-automated Slide Staining System for Labs of all Sizes

Manufactured by Siemens Healthcare, the Hematek® 3000 System is a semi-automated slide staining solution that is capable of staining up to 60 slides per hour. Specifically designed for hematology labs, the system can be used in lower volume settings as a primary slide staining solution or in larger laboratories as a backup to fully automated [...]

14 08, 2017

Siemens Healthineers to Acquire Epocal from Alere

By |August 14th, 2017|Siemens Healthcare|Comments Off on Siemens Healthineers to Acquire Epocal from Alere

Siemens Healthineers, the healthcare unit of Siemens recently announced its decision to acquire Epocal Inc., a subsidiary of Alere Inc, a global manufacturer of rapid point-of-care diagnostic tests. Epocal Inc offers point of care blood diagnostic systems for healthcare enterprises, including epoc Blood Analysis System. This acquisition will bring the handheld epoc Blood Analysis System [...]

2 05, 2016

Siemens Healthcare and Roche Diagnostics Lead the US Immunochemistry Market – Reports iData

By |May 2nd, 2016|Roche Diagnostics, Siemens Healthcare|Comments Off on Siemens Healthcare and Roche Diagnostics Lead the US Immunochemistry Market – Reports iData

As per the latest report on the in-vitro diagnostics device market from iData Research, increasing immunoassay test volumes is the major factor that drives growth in the immunochemistry market. The growth may be the result of high incidence of cardiovascular disorders and cancers among aging baby boomers coupled with unhealthy lifestyle choices. The report that [...]

27 04, 2016

Siemens Healthcare and Thermo Fisher Team Up to Boost Molecular Testing

By |April 27th, 2016|Siemens Healthcare, Thermo Scientific|Comments Off on Siemens Healthcare and Thermo Fisher Team Up to Boost Molecular Testing

Clinical laboratories utilize molecular diagnostics for early and more accurate detection of disease. Molecular testing involves measurement and analysis of DNA and RNA at the molecular level to detect changes in biochemical pathways. The aim of performing these tests is to determine the location of a disease and its activity. One of the most recent [...]

18 11, 2014

Siemens Joins Team to Build the Lab of the Future

By |November 18th, 2014|DNA Analyzer, Siemens Healthcare|Comments Off on Siemens Joins Team to Build the Lab of the Future

Siemens recently announced that it has joined forces with industry leader Inpeco to build a customized 'lab of the future' for Quest Diagnostics in Marlborough, MA. According to the terms of this exclusive contract, Siemens Healthcare and Inpeco will be responsible for automating the new clinical laboratory which will be the first comprehensive automation solution [...]

1 10, 2014

Quality Reagent Test Strips to Help Diabetes Management

By |October 1st, 2014|Siemens Healthcare|Comments Off on Quality Reagent Test Strips to Help Diabetes Management

Reagent test strips have transformed labor-intensive clinical analysis of urine and blood into a simple dip-and-read test. Results are obtained using instruments or visual manual reading as thresholds and quantitative outputs, and are accurate and available immediately, taking patient monitoring and diagnostic testing to new levels. Test results are also comparable to those obtained using [...]

4 09, 2014

Global Microbial Identification Market to Reach $1,194.1 Million by 2019

By |September 4th, 2014|Siemens Healthcare|Comments Off on Global Microbial Identification Market to Reach $1,194.1 Million by 2019

Microbial identification or identification of microorganisms such as harmful bacteria and fungi plays a central role in the quality control (QC) microbiology lab. Identification measures of microbes include - microscopy and specimen biochemical test. The ability to identify exactly which microorganism strain is present in a sample is a fundamental need of almost all microbiologists. [...]